IL-8 is a powerful chemoattractant for neutrophils and other immune-suppressive cells and elevated baseline levels of serum IL-8 correlate with reduced clinical benefit of ICI in different advancer cancer [82]. The gene discussed is CXCL8; the disease is cancer.